Dr. Philip is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 The Vanderbilt Clinic
Nashville, TN 37232Phone+1 615-936-2000Fax+1 615-936-7602
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2006 - 2011
University of ChicagoResidency, Internal Medicine, 2004 - 2006
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2004
Certifications & Licensure
TN State Medical License 2017 - 2026
WA State Medical License 2006 - 2018- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 599 citationsChromatin states define tumour-specific T cell dysfunction and reprogrammingMary Philip, Lauren Fairchild, Liping Sun, Ellen L. Horste, Steven Camara
Nature. 2017-05-17 - 409 citationsCD8+ T cell differentiation and dysfunction in cancerMary Philip, Andrea Schietinger
Nature Reviews. Immunology. 2021-07-12 - 654 citationsTOX is a critical regulator of tumour-specific T cell differentiationAndrew Scott, Friederike Dündar, Paul Zumbo, Smita S. Chandran, Christopher A. Klebanoff
Nature. 2019-06-17
Press Mentions
Study Shows Cancer Vaccine Blocks Tumor Progression at Early Lesion StageOctober 9th, 2024- Study Shows Cancer Vaccine Blocks Tumor Progression at Early Lesion StageOctober 7th, 2024
Study Identifies Critical Regulator of Tumor-Specific T Cell DifferentiationJune 18th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
